13.00–16.00 – Behavioural therapy for tic disorders: from assessment to treatment (English)

Speakers:

Zsanett Tarnok, Clinical Psychologist/Neuropsychologist, Vadaskert Child and Adolescent Psychiatry Budapest, Hungary

Tara Murphy, Consultant Clinical Psychologist, Great Ormond Street Hospital NHS Trust, London, United Kingdom

Jolande van der Griendt, Jolande van de Griendt: Health Psychologist/Cognitive Behavioural Therapist, TicXperts, The Netherlands

Cara Verdellen, Clinical Psychologist/Behavioural Therapist, TicXperts and Parnassia Group/PsyQ Nijmegen, The Netherlands

13.00–14.00 – ENIGMA-TS progress update session

14.30–15.30 – PANDAS/PANS interest group

16.00–16.45 – Patient advocacy session

16.45–17.30 – Opening ceremony

Keynote lecture: In the borderland of normality – tics as models of increased perception action binding

Alexander Münchau, Department of Pediatric and Adult Movement Disorders and Neuropsychiatry, Institute of Neurogenetics, Center for Brain, Behavior and Metabolism, University of Lübeck, Germany

18.30–19.30 – Social arrangement: Canal tour with snacks

8.30–10.30 – Update on etiology (genetics – non-genetic risk factors)

Co-chairs:

Peristera Paschou, Department of Biological Sciences, Purdue University, West Lafayette, IN, USA

Zeynep Tümer, Kennedy Center, Department of Clinical Genetics, The Juliane Marie Centre, Copenhagen University Hospital

8.30–9.00 – Updates on large scale collaborative studies for Tourette Syndrome

Peristera Paschou, Department of Biological Sciences, Purdue University, West Lafayette, IN, USA

9.00–9.30 – Structural variants and protein networks in Tourette Syndrome

Zeynep Tümer, Kennedy Center, Department of Clinical Genetics, Copenhagen University Hospital, Denmark

9.30–10.00 – Twin studies in Tourette and other psychiatric disorders

Thomas Werge, Department of Clinical Medicine, Region Hovedstadens Psykiatri, Boserupvej, Roskilde, Copenhagen, Denmark

10.00–10.30 – Oral presentations selected from submitted abstracts (TBA)

Thomas Werge, Department of Clinical Medicine, Region Hovedstadens Psykiatri, Boserupvej, Roskilde, Copenhagen, Denmark

10.30–11.00 – Coffee break

11.00–13.00 – Immunity, environment and tic disorders

Co-chairs:

Davide Martino, University of Calgary, Canada

Pieter Hoekstra, University of Groningen, The Netherlands

11.00–11.45 – Update on PANS and PANDAS

Tanya Murphy, University of South Florida, St Petersburg, FL, US

11.45–12.30 – Early environmental insults and autoimmunity in tic disorders: What are we learning from population-based studies?

David Mataix-Cols, Karolinska Institutet, Stockholm, Sweden

12.30–13.00 – Oral presentations selected from submitted abstracts (TBA)

13.00–14.00 – Lunch/poster session

14.00–16.00 – Neurobiology of Tourette Syndrome

Co-chairs:

Yulia Worbe, Faculté de Medecine, Sorbonne Université, Paris, France

Christos Ganos, Department of Neurology, University Hospital Charité, Berlin, Germany

14.00–14.45 – The role of dopamine in Tourette Syndrome: a computational account

Tiago Maia, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Portugal

14.45–15.30 – Insights from animal models on the pathophysiology of tics and comorbid symptoms

Izhar Bar-Gad, The Leslie and Susan Gonda Brain Research Center, Bar-Ilan University, Ramat-Gan, Israel

15.30–16.00 – Oral presentations selected from submitted abstracts (TBA)

16.15–17.15 – General Assembly meeting

18.00–19.00 – Reception at Copenhagen City Hall

From 19.30 – Dinner in Tivoli

8.30–10.00 – Comorbidities

Co-chairs:

Renata Rizzo, Department of Clinical and Experimental Medicine, Child and Adolescent Neurology and Psychiatry, Catania University, Catania, Italy

Kerstin Plessen, Child and Adolescent Mental Health Centre Copenhagen, Denmark & Division of Adolescent and Child Psychiatry, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland

8.30–9.00 – Comorbidities in clinical versus non-clinical populations of children and adolescents with TS

Elena Cravedi, Department of Child and Adolescent Psychiatry, Pitié-Salpêtrière Hospital, France & Pediatric Neurology Unit, University of Firenze, Florence, Italy

9.00–9.30 – Course of Tourette Syndrome and comorbidities in a large prospective clinical study

Camilla Groth, Paediatric Department, Herlev University Hospital, Herlev, Denmark

9.30–10.00 – Oral presentations selected from submitted abstracts (TBA)

10.00–10.30 – Coffee break

10.30–12.30 – TREATMENT

Co-chairs:

Danielle Cath, Department of Psychiatry and RGOC, University Medical Center Groningen, The Netherlands

Veit Roessner, Department of Child and Adolescent Psychiatry, Faculty of Medicine, TU Dresden, Germany

10.30–11.00 – Efficacy and safety of the cannabinoid modulator ABX-1431 in Tourette Syndrome: results from a phase 1b study

Kirsten Müller-Vahl, Department of Psychiatry, Socialpsychiatry and Psychotherapy, Hannover Medical School, Hannover, Germany

11.00–11.30 – An update on deep brain stimulation on Tourette Syndrome

Tom Foltynie, Sobell Department of Motor Neuroscience, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, London, UK

11.30–12.00 – Oral presentations selected from submitted abstracts (TBA)

12.00–12.45 – Keynote lecture: Evidenced-based and emerging treatments for Tourette Syndrome

Michael Bloch, Yale Child Study Center, Department of Psychiatry, Yale University, New Haven, CT, United States

12.45–14.00 – Lunch/poster session

14.00–14.30 – The Professor Mary Robertson Award

14.30–16.00 – Hot topics – discussion of hot topics and controversies from submitted abstracts of the meeting

Co-chairs:

Andrea Cavanna, Department of Neuropsychiatry, The Barberry National Centre for Mental Health, Birmingham, UK

Nanette Mol Debes, Department of Paediatrics, Herlev University Hospital, Herlev, Denmark

16.00–17.30 – Clinical rounds – clinical presentation and discussion of submitted cases

Co-chairs:

17.30 – Closing ceremony